Cynthia Weber is an award-winning educator and researcher, with more than 20 years experience in writing, editing, and project management within the publishing and marketing communication fields. She’s fascinated by the way language is articulated to convey meaning, and her current research projects examine ethics and technology and look at the social and political future of humanity. She holds both a master’s and Ph.D. in rhetoric and technical communication from Michigan Technological University, and has been an editor for IEEE Pulse since 2009.
The second NeuroCAS event in October 2018 was attended by researchers and entrepreneurs across the fields of bio-signals and neurotechnology. This collaborative workshop provided an opportunity for those within the larger biomedical circuits and systems community interested in brain activity and neurotechnology to interact, hear perspectives outside of their community, and discuss current challenges as well as new opportunities across the fields of electrocorticography and brain-body axis interfaces.
IEEE Pulse recently spoke with Timnit Gebru about the role societal bias plays in engineering AI, the deficits and dangers in the field caused by limited diversity, and the challenges inherent in addressing these complex issues.
Jeffrey Ardell, Founding Director of the UCLA Neurocardiology Research Program of Excellence, is a fellow of the American Heart Association and has been one of the principal investigators in the field of neurocardiology for the last three decades. IEEE Pulse recently spoke with him about the role neuromodulation will play in cardiac disease intervention.
Highlighting new research and key questions, the IEEE Brain Initiative Workshop brought together experts from interdisciplinary areas to discuss the future of advanced neurotechnologies, as well as ethical considerations when working with the brain.
Chad Bouton, director of the Center for Bioelectronic Medicine and vice president of advanced engineering at the Feinstein Institute for Medical Research, which serves as the research arm of one of the largest health systems in the United States, has spent nearly two decades developing innovative medical technology and products that help diagnose and treat conditions including cancer, stroke, diabetes, and paralysis.
As we look back over 2016 at IEEE Pulse, we can proudly say that our efforts to bring you up-to-date and informative articles that span the EMB spectrum have paid off. IEEE Pulse began the year with a comprehensive look at what’s new in wearables,
Project ECHO is a collaborative model of medical education and care management that empowers clinicians by providing the mentoring they need to treat their patient’s complex conditions where they live.
IEEE Pulse talks with Michael Wasser, co-founder of HealthSherpa and CEO of BloomAPI, about the changing landscape for electronic medical records, and the future of healthcare interoperability and innovation.
IEEE Pulse: You have founded at least four companies already, correct? How did you get in the
It’s early morning and the fog is lifting over the mountains. Several middle school students have been seen running into the school. What’s the hurry? Turns out there are zombies on the loose!
When it comes to biomedical engineering (BME) today, innovation might just be the most important buzzword around. That’s not because it happens to be the trend of the day across industries already; it’s because in the face of skyrocketing healthcare costs, a rapidly aging global population, and multiplying cases of chronic diseases such as diabetes, cardiovascular disease, and cancer, we have no other choice. If our goal is ultimately to create a healthier, more vibrant global society, we must innovate—and radically.